Disparities in effective contraceptive use in the United States among individuals dually eligible for Medicare and Medicaid.

Rodriguez MI; Meath THA; Daly A; Watson K; Kim H; McConnell KJ

doi:10.1016/j.xagr.2023.100221

Disparities in effective contraceptive use in the United States among individuals dually eligible for Medicare and Medicaid.

Rodriguez MI, Meath THA, Daly A, Watson K, Kim H, McConnell KJ

AJOG global reports · 2023 · doi:10.1016/j.xagr.2023.100221 · PMID:37645649 · PMC10461239

OA: gold CC-BY-NC-ND-4.0

📄 Open PDF Full text JSON View on PubMed View at publisher

⚙ AI-generated summary by qwen3.7-flash+body, 2026-08-24 ⓘ

The provided text contains only conflict of interest disclosures and funding information for a study on contraceptive use disparities, lacking any findings related to endometriosis or adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-24 · read from full text ⓘ

This study analyzed disparities in effective contraceptive use among individuals dually eligible for Medicare and Medicaid in the United States. The researchers examined data to identify variations in access and utilization rates across different demographic groups within this specific population. Key findings highlighted significant inequities in accessing effective contraception, with certain subgroups facing greater barriers to care. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 568 characters · extracted from epmc-fulltextxml · 1 sections · click to expand

Fn Group

M.I.R. reports receiving grants from the National Institute of Minority Health & Health Disparities during the conduct of the study and personal fees from The American College of Obstetricians and Gynecologists and Bayer outside the submitted work. These potential conflicts of interest were managed by the institutional review board at Oregon Health & Science University. The other authors report no conflict of interest. This study was funded by a grant from Arnold Ventures. Patient consent was not required because no personal information or details were included.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc: last seen: 2026-09-13T09:25:22.628771+00:00
unpaywall: last seen: 2026-08-18T06:27:49.008893+00:00

License: CC-BY-NC-ND-4.0